Hsbc Holdings PLC Acquires New Stake in Revvity Inc. $RVTY

Hsbc Holdings PLC purchased a new position in Revvity Inc. (NYSE:RVTY) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 177,678 shares of the company’s stock, valued at approximately $19,762,000. Hsbc Holdings PLC owned about 0.16% of Revvity at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. BlackRock Inc. bought a new position in shares of Revvity during the 2nd quarter worth $852,070,000. Primecap Management Co. CA bought a new position in shares of Revvity during the second quarter valued at approximately $94,921,000. Norges Bank bought a new position in shares of Revvity during the fourth quarter valued at approximately $80,382,000. Bank of New York Mellon Corp purchased a new position in Revvity during the second quarter valued at approximately $78,766,000. Finally, Morgan Stanley increased its holdings in Revvity by 29.6% during the fourth quarter. Morgan Stanley now owns 2,844,464 shares of the company’s stock valued at $275,202,000 after buying an additional 650,083 shares during the period. Institutional investors own 86.65% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on RVTY. Sanford C. Bernstein started coverage on Revvity in a report on Friday, June 26th. They issued a “market perform” rating and a $115.00 price target on the stock. Wall Street Zen cut Revvity from a “buy” rating to a “hold” rating in a research note on Sunday, August 16th. Stifel Nicolaus cut their target price on Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research note on Wednesday, May 6th. Weiss Ratings upgraded Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 30th. Finally, TD Cowen reiterated a “buy” rating on shares of Revvity in a report on Wednesday, July 15th. Three research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $108.36.

Revvity Stock Performance

RVTY opened at $129.30 on Friday. The firm has a fifty day moving average price of $113.52 and a 200 day moving average price of $101.02. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $129.80. The stock has a market cap of $14.43 billion, a P/E ratio of 61.57, a P/E/G ratio of 2.30 and a beta of 1.07.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. The company had revenue of $729.69 million during the quarter, compared to analysts’ expectations of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The firm’s revenue for the quarter was down 1.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Equities research analysts anticipate that Revvity Inc. will post 5.36 earnings per share for the current year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be given a dividend of $0.07 per share. The ex-dividend date is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. Revvity’s payout ratio is presently 13.33%.

Revvity News Summary

Here are the key news stories impacting Revvity this week:

• Positive Sentiment: Zacks Research raised its FY2026 EPS forecast to $5.38 from $5.25, slightly above the $5.36 consensus estimate. The firm also increased its FY2027 forecast to $5.86 from $5.77, while lifting Q1 2027 EPS to $1.17 and Q4 2027 EPS to $1.77. These revisions suggest improving expectations for longer-term earnings growth. Revvity analyst estimates
• Neutral Sentiment: Zacks maintained a Hold rating, limiting the bullish impact of the higher estimates. Revvity’s latest reported quarter also exceeded expectations, with EPS of $1.41 versus the $1.21 consensus and revenue of $729.7 million versus $703.0 million, although revenue declined 1.3% year over year.
• Neutral Sentiment: An analysis highlighted that Revvity faces a new test after its strong advance. With the shares near their annual high, investors may focus on whether future operating improvement can justify the recent valuation and momentum. Revvity faces a new test after its strong run
• Negative Sentiment: Zacks lowered several quarterly forecasts, including Q3 2026 EPS to $1.27 from $1.30, Q4 2026 EPS to $1.64 from $1.67, Q3 2027 EPS to $1.42 from $1.44, and Q2 2028 EPS to $1.62 from $1.64. The cuts indicate some uncertainty around near-term earnings momentum.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.